| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/12/2004 | US20040029761 O/W emulsion composition and method of preparing the same |
| 02/12/2004 | US20040029250 Method and device for sanitation using bacteriophages |
| 02/12/2004 | US20040029241 Formulation and use of a polymerization process employing biocompatible polymers and biocompatible polymerization conditions, such as neutral pH, where there is maintenance of an aqueous environment |
| 02/12/2004 | US20040029202 By determining a level of an estrogen- related marker; screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT; treating peri-, menopausal or postmenopausal women |
| 02/12/2004 | US20040029099 Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
| 02/12/2004 | US20040028772 Method for preparation of chewing gum with customer acceptable taste |
| 02/12/2004 | US20040028765 Apparatus for home-made tablet-making |
| 02/12/2004 | US20040028752 Hemorrhoids therapy |
| 02/12/2004 | US20040028750 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
| 02/12/2004 | US20040028748 Remedies for dermatophytosis |
| 02/12/2004 | US20040028747 High speed dissolving; bioavailability; drug with stabilzer |
| 02/12/2004 | US20040028746 Crystalline drug particles prepared using a controlled precipitation (recrystallization) process |
| 02/12/2004 | US20040028744 Topical applying; bioadhesive for mucous membrane; low temperature storage stability |
| 02/12/2004 | US20040028743 Brandycardial agents |
| 02/12/2004 | US20040028741 Oral preparations with favorable disintegration characteristics |
| 02/12/2004 | US20040028740 Transferring to cells; gene therapy; active drug in lipophilic matrix |
| 02/12/2004 | US20040028739 Wound gels |
| 02/12/2004 | US20040028738 Process for the preparation of porous collagen matrix |
| 02/12/2004 | US20040028737 Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same |
| 02/12/2004 | US20040028736 Macromolecules; oral administering; mixture of active material and aromatic alcohol |
| 02/12/2004 | US20040028735 Pharmaceutical formulation |
| 02/12/2004 | US20040028734 Muscular disorders; antiproliferative agents; antiinflammatory agents |
| 02/12/2004 | US20040028733 Therapy for fertility disorders; stabilized follicle stimulating hormone |
| 02/12/2004 | US20040028732 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 02/12/2004 | US20040028731 Active materials in pellet; veterinary medicine; fungicides, nematocides, parasiticides |
| 02/12/2004 | US20040028730 Process for preparing solid dosage forms for unpalatable pharmaceuticals |
| 02/12/2004 | US20040028729 Releasing into stomach; cone shapes of active materials in matrix; rolling compaction |
| 02/12/2004 | US20040028728 Liposome preparations |
| 02/12/2004 | US20040028727 Dry formulation for transcutaneous immunization |
| 02/12/2004 | US20040028726 Transdermal systems for the delivery of clonidine |
| 02/12/2004 | US20040028725 Transdermal delivery of hormones |
| 02/12/2004 | US20040028724 Pharmaceutical preparation of percutaneous absorption type |
| 02/12/2004 | US20040028723 Matrix with permeable reservoir containing ergoline compound; diffusion barrier |
| 02/12/2004 | US20040028722 Microbial cellulose wound dressing for treating chronic wounds |
| 02/12/2004 | US20040028721 Film for active ingredients dermal and transdermal administration |
| 02/12/2004 | US20040028707 Enhanced pharmacokinetic profile of intradermally delivered substances |
| 02/12/2004 | US20040028698 Vaccine |
| 02/12/2004 | US20040028694 Novel nanoparticles and use thereof |
| 02/12/2004 | US20040028655 Tissue engineering; drug delivery; fiber with hollow bore |
| 02/12/2004 | US20040028645 Artificial tear composition adapted to be used with contact lenses |
| 02/12/2004 | US20040028639 Cholesterol sulfate compositions for enhancement of stratum corneum function |
| 02/12/2004 | US20040028638 Carboxylic acid-type lipid |
| 02/12/2004 | US20040028635 Block-structure copolymer consisting of a saccharide segment bound to at least a biodegradable hydrophobic segment, and corresponding particles |
| 02/12/2004 | US20040028625 Transdermal delivery of analgesics |
| 02/12/2004 | US20040028619 Antiinflammatory agents; bronchodilator agents; antihistamines; respiratory system disorders |
| 02/12/2004 | US20040028618 Powder aerosol mixture containing propellant gas mixtures |
| 02/12/2004 | US20040028617 Mixture with alcohol carrier; administering to drug nose mucous membrane; side effect reduction |
| 02/12/2004 | US20040028616 Dna-polyethylenimine complex; aerosol administering gene and anticancer agents |
| 02/12/2004 | US20040028615 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/12/2004 | US20040028582 Using solvent, nonsolvent precipitation of drugs |
| 02/12/2004 | US20040026812 Apparatus for bench scale tablet-making |
| 02/12/2004 | US20040026804 Generation of nanoparticles and microparticles of controllable size using acoustic and ultrasonic vibration |
| 02/12/2004 | US20040025876 Capsules for dry powder inhalers and methods of making and using same |
| 02/12/2004 | DE19949252B4 Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung Use of a superficial therapeutic system for the topical application of acetylsalicylic acid for the treatment of acne diseases and process for its preparation |
| 02/12/2004 | DE19850517B4 Verwendung eines wirkstoffhaltigen transdermalen therapeutischen Systems in einer Kombinationsbehandlung mit und ohne Ultraschall Use of a drug-containing transdermal therapeutic system in combination treatment with and without ultrasound |
| 02/12/2004 | DE19847252B4 Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron Buccally administered bioadhesive systems with timed-release containing testosterone esters and optionally additionally testosterone |
| 02/12/2004 | DE10234531A1 Use of a mixture of citric acid, sodium citrate and potassium bicarbonate to prepare a medicament for treating sun allergy |
| 02/12/2004 | DE10233622A1 Infusionspumpe, Verfahren, Steuerprogramm und Halbleiterbauelement zur dosierten Verabreichung einer medizinischen Flüssigkeit The infusion pump, method, control program, and semiconductor device for the metered administration of a medical fluid |
| 02/12/2004 | DE10154016B4 Magnetflüssigkeit und Verfahren zur ihrer Herstellung Magnetic fluid and process for its preparation |
| 02/12/2004 | CA2495447A1 Anti-microbial compositions and methods of using same |
| 02/12/2004 | CA2494378A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 02/12/2004 | CA2494342A1 Injectable depot compositions and uses thereof |
| 02/12/2004 | CA2494316A1 Improved injection system |
| 02/12/2004 | CA2494281A1 Sustained release formulations of metformin |
| 02/12/2004 | CA2494280A1 Crystalline drug particles prepared using a controlled precipitation process |
| 02/12/2004 | CA2494277A1 Crystalline drug particles prepared using a controlled precipitation (recrystallization) process |
| 02/12/2004 | CA2494212A1 Oral administration of calcitonin |
| 02/12/2004 | CA2494211A1 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 02/12/2004 | CA2494017A1 Delayed release anti-viral product, use and formulation thereof |
| 02/12/2004 | CA2493786A1 Process for making orally consumable dosage forms |
| 02/12/2004 | CA2493750A1 Methods and compositions for treating benign gynecological disorders, contraception, and hormone replacement |
| 02/12/2004 | CA2493593A1 Bicifadine formulation |
| 02/12/2004 | CA2493478A1 Cell transport compositions and uses thereof |
| 02/12/2004 | CA2493301A1 Sustained release formulations comprising lamotrigine |
| 02/12/2004 | CA2493289A1 A pharmaceutical formulation and its use in the treatment of inner ear diseases |
| 02/12/2004 | CA2491366A1 Improved transdermal delivery system for the administration of rotigotine |
| 02/11/2004 | EP1388371A2 A dispensing device and method for forming material |
| 02/11/2004 | EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases |
| 02/11/2004 | EP1388340A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient |
| 02/11/2004 | EP1387844A1 Retinol derivatives potentiation of active substances by micellar preparation |
| 02/11/2004 | EP1387713A1 Method of preventing type 2 diabetes with aerosolized insulin |
| 02/11/2004 | EP1387703A1 Fibrin material and method for producing and using the same |
| 02/11/2004 | EP1387699A1 Agent for improving tissue penetration |
| 02/11/2004 | EP1387689A1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| 02/11/2004 | EP1387676A2 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
| 02/11/2004 | EP1387675A2 Liquid formulation of metformin |
| 02/11/2004 | EP1387673A1 Abuse-resistant controlled-release opioid dosage form |
| 02/11/2004 | EP1387672A1 Flavored product containing medicament or other active agent |
| 02/11/2004 | EP1387671A1 Implantable drug delivery device and use thereof |
| 02/11/2004 | EP1387670A2 Immune modulation device for use in animals |
| 02/11/2004 | EP1387669A1 Concentrated w/o emulsion |
| 02/11/2004 | EP1387665A2 System for delivering cosmetics and pharmaceuticals |
| 02/11/2004 | EP1300394B1 Method for the production of a water-dispersible formulation containing carotenoids |
| 02/11/2004 | EP1257259A4 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| 02/11/2004 | EP1240157B1 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 02/11/2004 | EP1227795B1 Lipid complex of alkycyclines |
| 02/11/2004 | EP1225876B1 Gastroresistant tablets for alimentary, dietetic and therapeutic use |
| 02/11/2004 | EP1180944B1 Compositions containing creatine in suspension |
| 02/11/2004 | EP1180033B1 Lamivudine containing pharmaceutical formulation |
| 02/11/2004 | EP1176962B1 Liposome compositions for improved drug retention |